Prostate Cancer - Results from #20700

Overdetection in screening for prostate cancer - Abstract April 28, 2014

Proactive rectal warming during total-gland prostate cryoablation - Abstract April 25, 2014

Circulating MicroRNAs in blood of patients with prostate cancer - Abstract April 25, 2014

Assessing the dosimetric impact of real-time prostate motion during volumetric modulated arc therapy - Abstract April 25, 2014

Intrafraction prostate translations and rotations during hypofractionated robotic radiation surgery: Dosimetric impact of correction strategies and margins - Abstract April 25, 2014

Psychological distress and adjustment to disease in patients before and after radical prostatectomy. Results of a prospective multi-centre study - Abstract April 25, 2014

Drug and device development for localized prostate cancer: Report of a Food and Drug Administration/American Urological Association public workshop - Abstract April 25, 2014

Twitter response to the United States Preventive Services Task Force recommendations against screening with prostate specific antigen - Abstract April 25, 2014

Relationship between radiation-induced apoptosis of T lymphocytes and chronic toxicity in patients with prostate cancer treated by radiation therapy: A prospective study - Abstract April 25, 2014

The impact of definitive local therapy for lymph node-positive prostate cancer: A population-based study - Abstract April 25, 2014

Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: Results from a randomized trial - Abstract April 25, 2014

ETS fusion genes in prostate cancer - Abstract April 25, 2014

Robot-assisted radical prostatectomy in the Korean population: A 5-year propensity-score matched comparative analysis versus open radical prostatectomy - Abstract April 25, 2014

Perioperative allogeneic nonleukoreduced blood transfusion and prostate cancer outcomes after radical prostatectomy - Abstract April 25, 2014

Percent free prostate-specific antigen does not improve the effectiveness of prostate cancer detection in Chinese men with a prostate-specific antigen of 2.5-20.0 ng/ml: A multicenter study - Abstract April 25, 2014

Single-nucleotide polymorphisms studied for associations with urinary toxicity from 125I prostate brachytherapy implants - Abstract April 24, 2014

Circumcision and prostate cancer: A population-based case-control study in Montreal, Canada - Abstract April 24, 2014

PSA response to neoadjuvant androgen deprivation is an independent prognostic marker and may identify patients who benefit from treatment escalation - Abstract April 24, 2014

Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy - Abstract April 24, 2014

New agents for prostate cancer - Abstract April 24, 2014

Page 1036 of 1436